CA2050677C - Methode de mesure visuelle de la glycemie - Google Patents

Methode de mesure visuelle de la glycemie Download PDF

Info

Publication number: CA2050677C
Authority: CA; Canada
Prior art keywords: matrix; acid; sample; reagent; whole blood
Prior art date: 1990-09-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA 2050677

Other languages

English (en)

Other versions

CA2050677A1 (fr

Inventor

Ernest J. Kiser

Edward G. Rice

Michael F. Tomasco

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LifeScan Inc

Original Assignee

LifeScan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-06

Filing date

1991-09-04

Publication date

2003-04-08

1991-09-04 Application filed by LifeScan Inc filed Critical LifeScan Inc

1992-03-07 Publication of CA2050677A1 publication Critical patent/CA2050677A1/fr

2003-04-08 Application granted granted Critical

2003-04-08 Publication of CA2050677C publication Critical patent/CA2050677C/fr

2011-09-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000012360 testing method Methods 0.000 title claims abstract description 123
210000004369 blood Anatomy 0.000 title claims abstract description 99
239000008280 blood Substances 0.000 title claims abstract description 99
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 38
239000008103 glucose Substances 0.000 title claims abstract description 38
230000000007 visual effect Effects 0.000 title claims abstract description 25
239000011159 matrix material Substances 0.000 claims abstract description 162
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 107
238000000926 separation method Methods 0.000 claims abstract description 47
239000012491 analyte Substances 0.000 claims abstract description 40
239000012530 fluid Substances 0.000 claims abstract description 36
210000003743 erythrocyte Anatomy 0.000 claims abstract description 17
239000003112 inhibitor Substances 0.000 claims description 23
239000011248 coating agent Substances 0.000 claims description 13
238000000576 coating method Methods 0.000 claims description 13
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
239000002202 Polyethylene glycol Substances 0.000 claims description 10
229920001223 polyethylene glycol Polymers 0.000 claims description 10
239000011148 porous material Substances 0.000 claims description 10
RUDINRUXCKIXAJ-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-heptacosafluorotetradecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RUDINRUXCKIXAJ-UHFFFAOYSA-N 0.000 claims description 8
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 8
239000004366 Glucose oxidase Substances 0.000 claims description 8
108010015776 Glucose oxidase Proteins 0.000 claims description 8
235000019420 glucose oxidase Nutrition 0.000 claims description 8
229940116332 glucose oxidase Drugs 0.000 claims description 8
102000004190 Enzymes Human genes 0.000 claims description 7
108090000790 Enzymes Proteins 0.000 claims description 7
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 7
108010001336 Horseradish Peroxidase Proteins 0.000 claims description 7
-1 bromopyrolgallol red Chemical compound 0.000 claims description 7
239000000872 buffer Substances 0.000 claims description 7
FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 claims description 7
229940088598 enzyme Drugs 0.000 claims description 7
LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 7
229920000172 poly(styrenesulfonic acid) Polymers 0.000 claims description 7
229940005642 polystyrene sulfonic acid Drugs 0.000 claims description 7
229920002554 vinyl polymer Polymers 0.000 claims description 7
239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 claims description 6
KUQNCHZOCSYKOR-UHFFFAOYSA-N 1,1-dioxospiro[2,1$l^{6}-benzoxathiole-3,9'-xanthene]-3',4',5',6'-tetrol Chemical compound O1S(=O)(=O)C2=CC=CC=C2C21C1=CC=C(O)C(O)=C1OC1=C(O)C(O)=CC=C21 KUQNCHZOCSYKOR-UHFFFAOYSA-N 0.000 claims description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
229920002125 Sokalan® Polymers 0.000 claims description 6
229940091181 aconitic acid Drugs 0.000 claims description 6
GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 claims description 6
230000001419 dependent effect Effects 0.000 claims description 6
239000000463 material Substances 0.000 claims description 6
GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 claims description 6
IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims description 5
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 5
239000002253 acid Substances 0.000 claims description 5
239000001863 hydroxypropyl cellulose Substances 0.000 claims description 5
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 5
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
230000009471 action Effects 0.000 claims description 4
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
235000015165 citric acid Nutrition 0.000 claims description 4
239000001630 malic acid Substances 0.000 claims description 4
235000011090 malic acid Nutrition 0.000 claims description 4
239000004584 polyacrylic acid Substances 0.000 claims description 4
BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 claims description 3
PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 claims description 3
MCGBIXXDQFWVDW-UHFFFAOYSA-N 4,5-dihydro-1h-pyrazole Chemical compound C1CC=NN1 MCGBIXXDQFWVDW-UHFFFAOYSA-N 0.000 claims description 3
CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 3
229950004388 anazolene sodium Drugs 0.000 claims description 3
235000010323 ascorbic acid Nutrition 0.000 claims description 3
229960005070 ascorbic acid Drugs 0.000 claims description 3
239000011668 ascorbic acid Substances 0.000 claims description 3
239000002738 chelating agent Substances 0.000 claims description 3
QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 3
229960001484 edetic acid Drugs 0.000 claims description 3
235000010350 erythorbic acid Nutrition 0.000 claims description 3
YKYHYFKZYBXMCZ-UHFFFAOYSA-N ethyl 1,3-benzothiazole-2-sulfonate Chemical compound C1=CC=C2SC(S(=O)(=O)OCC)=NC2=C1 YKYHYFKZYBXMCZ-UHFFFAOYSA-N 0.000 claims description 3
239000001530 fumaric acid Substances 0.000 claims description 3
235000004515 gallic acid Nutrition 0.000 claims description 3
229940074391 gallic acid Drugs 0.000 claims description 3
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
229940026239 isoascorbic acid Drugs 0.000 claims description 3
229920001451 polypropylene glycol Polymers 0.000 claims description 3
230000000979 retarding effect Effects 0.000 claims description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
238000009826 distribution Methods 0.000 claims description 2
ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims 4
BBTNLADSUVOPPN-UHFFFAOYSA-N 5,6-diaminouracil Chemical compound NC=1NC(=O)NC(=O)C=1N BBTNLADSUVOPPN-UHFFFAOYSA-N 0.000 claims 2
ADGGJQPKBDIZMT-IAXIIBAVSA-K c12c(O)cc(S(=O)(=O)O[Na])cc2cc(S(=O)(=O)O[Na])cc1\N=N\c(c1c2c(ccc1)S(=O)(=O)O[Na])ccc2Nc1ccccc1 Chemical compound c12c(O)cc(S(=O)(=O)O[Na])cc2cc(S(=O)(=O)O[Na])cc1\N=N\c(c1c2c(ccc1)S(=O)(=O)O[Na])ccc2Nc1ccccc1 ADGGJQPKBDIZMT-IAXIIBAVSA-K 0.000 claims 2
235000010388 propyl gallate Nutrition 0.000 claims 2
239000000473 propyl gallate Substances 0.000 claims 2
229940075579 propyl gallate Drugs 0.000 claims 2
239000003795 chemical substances by application Substances 0.000 abstract description 9
102000001554 Hemoglobins Human genes 0.000 abstract description 8
108010054147 Hemoglobins Proteins 0.000 abstract description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
235000012000 cholesterol Nutrition 0.000 abstract description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
239000000306 component Substances 0.000 description 72
239000012528 membrane Substances 0.000 description 51
238000000034 method Methods 0.000 description 18
239000000243 solution Substances 0.000 description 18
229920003023 plastic Polymers 0.000 description 14
239000004033 plastic Substances 0.000 description 14
239000010410 layer Substances 0.000 description 13
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
230000008859 change Effects 0.000 description 12
239000000470 constituent Substances 0.000 description 12
239000004952 Polyamide Substances 0.000 description 10
229920002647 polyamide Polymers 0.000 description 10
239000007795 chemical reaction product Substances 0.000 description 8
238000005259 measurement Methods 0.000 description 8
229920002492 poly(sulfone) Polymers 0.000 description 8
229920000728 polyester Polymers 0.000 description 8
239000004698 Polyethylene Substances 0.000 description 6
239000000853 adhesive Substances 0.000 description 6
230000001070 adhesive effect Effects 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
OEZPVSPULCMUQB-VRTOBVRTSA-N hydron;(e)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine;chloride Chemical compound Cl.C1=CC=C2S\C(=N\N)N(C)C2=C1 OEZPVSPULCMUQB-VRTOBVRTSA-N 0.000 description 6
239000007788 liquid Substances 0.000 description 6
229920000573 polyethylene Polymers 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
239000003381 stabilizer Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
VMNDRLYLEVCGAG-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-3-methylanilino]ethanol Chemical compound CC1=CC=CC(N(CCO)CCO)=C1 VMNDRLYLEVCGAG-UHFFFAOYSA-N 0.000 description 4
LWKJNIMGNUTZOO-UHFFFAOYSA-N 3,5-dichloro-2-hydroxybenzenesulfonic acid Chemical compound OC1=C(Cl)C=C(Cl)C=C1S(O)(=O)=O LWKJNIMGNUTZOO-UHFFFAOYSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
239000000203 mixture Substances 0.000 description 4
ZUHZGEOKBKGPSW-UHFFFAOYSA-N tetraglyme Chemical compound COCCOCCOCCOCCOC ZUHZGEOKBKGPSW-UHFFFAOYSA-N 0.000 description 4
UCJKAZZVJXOLRP-UHFFFAOYSA-N 3-oxo-2-(4-sulfophenyl)-1h-pyrazole-5-carboxylic acid Chemical compound N1C(C(=O)O)=CC(=O)N1C1=CC=C(S(O)(=O)=O)C=C1 UCJKAZZVJXOLRP-UHFFFAOYSA-N 0.000 description 3
RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
239000004372 Polyvinyl alcohol Substances 0.000 description 3
238000013461 design Methods 0.000 description 3
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
238000005534 hematocrit Methods 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
239000002356 single layer Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
206010018910 Haemolysis Diseases 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
102000003992 Peroxidases Human genes 0.000 description 2
229920002873 Polyethylenimine Polymers 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
235000001014 amino acid Nutrition 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
239000012503 blood component Substances 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000007979 citrate buffer Substances 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000835 fiber Substances 0.000 description 2
230000008588 hemolysis Effects 0.000 description 2
239000003607 modifier Substances 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
108040007629 peroxidase activity proteins Proteins 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920000098 polyolefin Polymers 0.000 description 2
239000000047 product Substances 0.000 description 2
230000004044 response Effects 0.000 description 2
OGNVQLDIPUXYDH-ZPKKHLQPSA-N (2R,3R,4S)-3-(2-methylpropanoylamino)-4-(4-phenyltriazol-1-yl)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(O)=O)=C[C@@H]1N1N=NC(C=2C=CC=CC=2)=C1 OGNVQLDIPUXYDH-ZPKKHLQPSA-N 0.000 description 1
DVVXXHVHGGWWPE-UHFFFAOYSA-N 2-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC=C1C(O)=O DVVXXHVHGGWWPE-UHFFFAOYSA-N 0.000 description 1
MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
BOTGCZBEERTTDQ-UHFFFAOYSA-N 4-Methoxy-1-naphthol Chemical compound C1=CC=C2C(OC)=CC=C(O)C2=C1 BOTGCZBEERTTDQ-UHFFFAOYSA-N 0.000 description 1
235000011330 Armoracia rusticana Nutrition 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
229920002564 Polyethylene Glycol 3500 Polymers 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
CPOBTYJRKAJERX-KWNZBJHBSA-N S/1C2=CC=CC=C2N(CC)C\1=N/N=C1SC2=CC=CC=C2N1CC Chemical compound S/1C2=CC=CC=C2N(CC)C\1=N/N=C1SC2=CC=CC=C2N1CC CPOBTYJRKAJERX-KWNZBJHBSA-N 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
239000004927 clay Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000004020 conductor Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000004042 decolorization Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
150000004675 formic acid derivatives Chemical class 0.000 description 1
238000009472 formulation Methods 0.000 description 1
150000002337 glycosamines Chemical class 0.000 description 1
230000005484 gravity Effects 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
230000003993 interaction Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000003973 paint Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
229960005190 phenylalanine Drugs 0.000 description 1
229940068041 phytic acid Drugs 0.000 description 1
235000002949 phytic acid Nutrition 0.000 description 1
239000000467 phytic acid Substances 0.000 description 1
229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
229940057847 polyethylene glycol 600 Drugs 0.000 description 1
229910000057 polysulfane Inorganic materials 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000004080 punching Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
239000002964 rayon Substances 0.000 description 1
230000036632 reaction speed Effects 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
239000000758 substrate Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
230000007723 transport mechanism Effects 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000011800 void material Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Ecology (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA 2050677 1990-09-06 1991-09-04 Methode de mesure visuelle de la glycemie Expired - Lifetime CA2050677C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US57836490A	1990-09-06	1990-09-06
US578,364		1990-09-06

Publications (2)

Publication Number	Publication Date
CA2050677A1 CA2050677A1 (fr)	1992-03-07
CA2050677C true CA2050677C (fr)	2003-04-08

Family

ID=24312551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2050677 Expired - Lifetime CA2050677C (fr)	1990-09-06	1991-09-04	Methode de mesure visuelle de la glycemie

Country Status (1)

Country	Link
CA (1)	CA2050677C (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8326393B2 (en)	2005-12-19	2012-12-04	Roche Diagnostics Operations, Inc.	Layered sensor for determining an analyte concentration
US8828200B2 (en)	2006-08-08	2014-09-09	Roche Diagnostics Operations, Inc.	Electrochemical sensor for the determination of an analyte concentration
US11016052B2 (en)	2007-08-30	2021-05-25	Pepex Biomedical Inc.	Electrochemical sensor and method for manufacturing
US11045124B2 (en)	2014-06-04	2021-06-29	Pepex Biomedical, Inc.	Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology
US11150212B2 (en)	2007-08-30	2021-10-19	Pepex Biomedical, Inc.	Electrochemical sensor and method for manufacturing
US11224367B2 (en)	2012-12-03	2022-01-18	Pepex Biomedical, Inc.	Sensor module and method of using a sensor module
US11510595B2 (en)	2007-05-03	2022-11-29	Roche Diabetes Care, Inc.	Tubular sensor for the detection of an analyte

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1792563A1 (fr)	2005-12-02	2007-06-06	F.Hoffmann-La Roche Ag	Système d'analyse muni d'un élément d'affichage de type OLED
EP1797817A1 (fr)	2005-12-19	2007-06-20	F.Hoffmann-La Roche Ag	Capteur de type sandwich pour la détermination de la concentration des analytes
EP1894526A1 (fr)	2006-09-04	2008-03-05	F. Hoffmann-la Roche AG	Lancette
EP2040079B1 (fr)	2007-09-19	2009-05-20	F. Hoffman-la Roche AG	Procédé de marquage destiné au marquage de déchet d'éléments test
EP2228658A1 (fr)	2009-03-13	2010-09-15	Roche Diagnostics GmbH	Procédé de fabrication d'un moyen de consommation analytique
DE102015217785A1 (de) *	2015-09-17	2017-03-23	Robert Bosch Gmbh	Trockenchemisch gesteuerte Vorrichtung zur Analyse einer Probe biologischen Materials

1991
- 1991-09-04 CA CA 2050677 patent/CA2050677C/fr not_active Expired - Lifetime

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8326393B2 (en)	2005-12-19	2012-12-04	Roche Diagnostics Operations, Inc.	Layered sensor for determining an analyte concentration
US8997330B2 (en)	2005-12-19	2015-04-07	Roche Diagnostics Operations, Inc.	Layered sensor for determining an analyte concentration
US8828200B2 (en)	2006-08-08	2014-09-09	Roche Diagnostics Operations, Inc.	Electrochemical sensor for the determination of an analyte concentration
US9255903B2 (en)	2006-08-08	2016-02-09	Roche Diabetes Care, Inc.	Methods of producing an electrochemical sensor for determining an analyte concentration
US10060877B2 (en)	2006-08-08	2018-08-28	Roche Diabetes Care, Inc.	Electrochemical sensor for determining an analyte concentration
US11510595B2 (en)	2007-05-03	2022-11-29	Roche Diabetes Care, Inc.	Tubular sensor for the detection of an analyte
US11016052B2 (en)	2007-08-30	2021-05-25	Pepex Biomedical Inc.	Electrochemical sensor and method for manufacturing
US11150212B2 (en)	2007-08-30	2021-10-19	Pepex Biomedical, Inc.	Electrochemical sensor and method for manufacturing
US11224367B2 (en)	2012-12-03	2022-01-18	Pepex Biomedical, Inc.	Sensor module and method of using a sensor module
US11045124B2 (en)	2014-06-04	2021-06-29	Pepex Biomedical, Inc.	Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology

Also Published As

Publication number	Publication date
CA2050677A1 (fr)	1992-03-07

Legal Events

Date	Code	Title	Description
1998-08-31	EEER	Examination request
2011-09-04	MKEX	Expiry

Publication	Publication Date	Title
US5306623A (en)	1994-04-26	Visual blood glucose concentration test strip
US5418142A (en)	1995-05-23	Glucose test strip for whole blood
US4994238A (en)	1991-02-19	Constant volume chemical analysis test device
EP0654659B1 (fr)	1997-02-12	Dispositif d'épreuve de volume déterminé
KR100589871B1 (ko)	2006-06-15	시각적 혈중 글루코스 시험 스트립
JP3479434B2 (ja)	2003-12-15	容量非依存的診断試験担体および被検物質測定のためのその使用方法
US4987085A (en)	1991-01-22	Blood filtering metering device
TW514727B (en)	2002-12-21	Diagnostic test carrier with multi-layer test field
JP3173798B2 (ja)	2001-06-04	体液の分析対象成分を決定する方法および装置
EP0993614B1 (fr)	2006-10-25	Dispositif permettant de determiner un analysat dans un fluide biologique
US5460777A (en)	1995-10-24	Analytical element for whole blood analysis
CA2050677C (fr)	2003-04-08	Methode de mesure visuelle de la glycemie
JPH10191995A (ja)	1998-07-28	肉眼で判読可能な試薬検査細片
JPH1078432A (ja)	1998-03-24	診断試験用担体およびこれを用いて分析対象物を測定する方法
JPH03130662A (ja)	1991-06-04	血液から血漿を分離するための装置と方法および血液中の分析対象物の測定法
CA2519402A1 (fr)	2004-10-21	Membranes adherentes conservant une porosite et une activite biologique dans un dispositif d'essai concu pour mesurer le cholesterol serique associe a des lipoproteines haute densite
JP4681198B2 (ja)	2011-05-11	試験紙
JPH05322887A (ja)	1993-12-07	全血分析要素及びそれを用いた測定方法